Pfizer to invest $600 million in its venture fund, add more staff

Pfizer Inc. has announced plans to invest $600 million in its venture capital arm and also expand its venture capital efforts and team. Pfizer will add five new members to the venture investing team and consolidate its research and development equity investment vehicle with Pfizer Venture Investments. Read more here.

Tom Ballard

By Tom Ballard, Chief Alliance Officer,
Pershing Yoakley & Associates. P.C.

eNews & Updates

Sign up to receive posts via email.

Connect With Us

Upcoming Events

Links to Partners